(IN BRIEF) Fresenius Kabi is addressing the global threat of antimicrobial resistance (AMR), which causes millions of deaths annually, through sustainable manufacturing, improved antibiotic access, and promoting responsible use. During AMR Awareness Week, the company highlighted its commitment to reducing … Read the full press release
(IN BRIEF) In his doctoral research at the University of Helsinki, Matej Zore demonstrated the potential of repurposing the drugs fingolimod and etrasimod, originally developed for autoimmune diseases, to combat antimicrobial resistance (AMR). These drugs showed notable efficacy against drug-resistant … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged antimicrobial resistance, etrasimod, fingolimod, Matej Zore, methicillin-resistant Staphylococcus aureus (MRSA), Professor Fredrik Almqvist, Professor Jari Yli-Kauhaluoma, Repurposing Drugs, University of Helsinki, vancomycin-resistant Enterococcus (VRE)
(IN BRIEF) The University of Liverpool has secured £1.3m in funding to support the UK Government’s Fleming Fund Fellowship Programme, aimed at addressing antimicrobial resistance (AMR) in partner countries. Led by Professor Alison Holmes, the program will provide mentorship and … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, United Kingdom
Tagged antimicrobial resistance, Dr Derek Cocker, Dr Kat Stott, Dr Steve Aston, Fleming Fund Programme, Nigeria, partnership, Professor Alison Holmes, Sierra Leone, sustainability, University of Liverpool
(IN BRIEF) The University of Liverpool and the Global Antibiotic Research and Development Partnership (GARDP) have signed a Memorandum of Understanding to collaborate on new projects to address antimicrobial resistance (AMR). They have been working together since 2018 to advance … Read the full press release
Posted in Education, Healthcare, Non Profit, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged AMR, Antimicrobial Chemotherapy Conference, antimicrobial resistance, Dame Sally Davies, drug resistance, drug-resistant infections, GARDP, Global Antibiotic Research and Development Partnership, newborns, Professor William Hope, Seamus O’Brien, SEPSIS, the University of Liverpool
(IN BRIEF) Sandoz, a global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to acquire worldwide product rights for leading systemic antifungal agent Mycamine® (micafungin sodium, Funguard® in Japan) from Astellas. This acquisition will reinforce Sandoz’s hospital … Read the full press release
Workshop with regulators from EU, Japan and US open for registration LONDON, 28-May-2018 — /EuropaWire/ — The European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and the United States’ Food and Drug Administration (FDA) are co-organising a workshop to discuss the development … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged antibiotics for children, antimicrobial resistance, EMA, FDA, PMDA, workshop
Dundee, Scotland, 27-Mar-2017 — /EuropaWire/ — Antimicrobial resistance is one of the greatest threats to global human and animal health – the O’Neill Report published last year stated that, unless we take urgent action, it will be directly responsible for over … Read the full press release
LEICESTER, 06-Jan-2017 — /EuropaWire/ — A researcher from the University of Leicester has been awarded a prestigious Research Councils grant to study antimicrobial resistance (AMR) from a new perspective. Dr Carolyn Tarrant, Associate Professor and co-lead of the SAPPHIRE research group … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
